Fingertip Facts 2010

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2011

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2012

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2002

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2003

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2004

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2005

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2006

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2007

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Fingertip Facts 2008

Santee Cooper annually published Fingertip Facts, which provides a snapshot of utility, including listings of leadership, comparative highlights, year in review, and description of their environmental stewardship.

Address of Mr. C. G. Memminger, to the people of St. Phillip's and St. Michael's, in relation to the Bank of the State : containing facts and arguments in favor of the bill, which he was prevented from presenting before the House, at the last session of the Legislature

This document contains the facts and arguments in favor of the bill, which he was prevented from presenting before the House of Representatives at the last session of the legislature.

Desenvolvimento e estudo de modelos de FACTS para o trânsito de energia: aplicação ao estudo das condições técnicas de ligação de linhas MAT

Dissertação para obtenção do grau de Mestre em Engenharia Electrotécnica Ramo de Energia

Targeting specific nutrient deficiencies in proteinrestricted diets: some practical facts in PKU dietary management

Among aminoacidopathies, phenylketonuria (PKU) is the most prevalent one. Early diagnosis in the neonatal period with a prompt nutritional therapy (low natural-protein and phenylalanine diet, supplemented with phenylalanine-free amino acid mixtures and special low-protein foods) remains the mainstay of the treatment. Data considering nutrient contents of cooked dishes is lacking. In this study, fourteen dishes specifically prepared for PKU individuals were analysed, regarding the lipid profile and iron and zinc contents. These dishes are poor sources of essential nutrients like Fe, Zn or n-3 fatty acids, reinforcing the need for adequate supplementation to cover individual patients’ needs. This study can contribute to a more accurate adjustment of PKU diets and supplementation in order to prevent eventual nutritional deficiencies. This study contributes to a better understanding of nutrient intake from PKU patients’ meals, showing the need for dietary supplementation.

Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS survey.

Background: Switzerland was the first country to approve certolizumab pegol (Cimzia, CZP) for the treatment of patients with moderate to severe Crohn's disease (CD) in September 2007. This phase IV study aimed to evaluate the efficacy and safety of CZP in a Swiss multicenter cohort of practice-based patients. Methods: Baseline and Week 6 evaluation questionnaires were sent to all Swiss gastroenterologists in hospitals and private practices. Disease activity was assessed with the Harvey-Bradshaw Index (HBI) and adverse events were evaluated according to WHO guidelines. Results: Fifty patients (31 women, 19 men) were included; 56% had complicated disease (stricture or fistula) and 52% had undergone prior CD-related surgery. All patients. had prior exposure to systemic steroids, 96% to immunomodulators, 78% to infliximab, and 50% to adalimumab. A significant decrease in HBI was observed at Week 6 (versus Week 0) following induction therapy with CZP 400 mg subcutaneously at Weeks 0, 2, and 4 (12.6 +/- 4.7 Week 0 versus 6.2 +/- 4.4 Week 6, P < 0.001). Response and remission rates at Week 6 were 54% and 40%, respectively. We identified 8/11 CD patients undergoing a 50% fistula response (P = 0.021). The frequency of adverse drug reactions attributed to CZP was 6%. CZP was continued in 80% of patients beyond Week 6. Conclusions: In a population of CD patients with complicated disease behavior, CZP induced a response and remission in 54% and 40% of patients, respectively. This series provides the first evidence of the effectiveness of CZP in perianal fistulizing CD.